COVID-19 Impact on Global Pharmacogenomics (PGx) Market Size, Status and Forecast 2020-2026

July 2020 | 133 pages | ID: C3390F752770EN
QYResearch

Abstracts

This report focuses on the global Pharmacogenomics (PGx) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacogenomics (PGx) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbott Laboratories
• Affymetrix, Inc.
• Assurex Health, Inc
• Astrazeneca
• GeneDX
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• Myriad Genetics, Inc.
• Pathway Genomics
• Pfizer, Inc
• Qiagen, Inc.
• Rocheg
• Teva Pharmaceutical Industries Ltd.
• Thermo Fisher Scientific
• Transgenomic, Inc.

Market segment by Type, the product can be split into

• Polymerase Chain Reaction (PCR)
• Microarray
• Sequencing
• Other

Market segment by Application, split into

• Cardiovascular Diseases (CVD)
• Central Nervous System (CNS)
• Cancer/Oncology
• Infectious Diseases
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pharmacogenomics (PGx) status, future forecast, growth opportunity, key market and key players.
• To present the Pharmacogenomics (PGx) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pharmacogenomics (PGx) are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmacogenomics (PGx) Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Polymerase Chain Reaction (PCR)
  1.4.3 Microarray
  1.4.4 Sequencing
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Pharmacogenomics (PGx) Market Share by Application: 2020 VS 2026
  1.5.2 Cardiovascular Diseases (CVD)
  1.5.3 Central Nervous System (CNS)
  1.5.4 Cancer/Oncology
  1.5.5 Infectious Diseases
  1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Pharmacogenomics (PGx) Industry Impact
  1.6.1 How the Covid-19 is Affecting the Pharmacogenomics (PGx) Industry
    1.6.1.1 Pharmacogenomics (PGx) Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Pharmacogenomics (PGx) Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Pharmacogenomics (PGx) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pharmacogenomics (PGx) Market Perspective (2015-2026)
2.2 Pharmacogenomics (PGx) Growth Trends by Regions
  2.2.1 Pharmacogenomics (PGx) Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pharmacogenomics (PGx) Historic Market Share by Regions (2015-2020)
  2.2.3 Pharmacogenomics (PGx) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pharmacogenomics (PGx) Market Growth Strategy
  2.3.6 Primary Interviews with Key Pharmacogenomics (PGx) Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pharmacogenomics (PGx) Players by Market Size
  3.1.1 Global Top Pharmacogenomics (PGx) Players by Revenue (2015-2020)
  3.1.2 Global Pharmacogenomics (PGx) Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pharmacogenomics (PGx) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmacogenomics (PGx) Market Concentration Ratio
  3.2.1 Global Pharmacogenomics (PGx) Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pharmacogenomics (PGx) Revenue in 2019
3.3 Pharmacogenomics (PGx) Key Players Head office and Area Served
3.4 Key Players Pharmacogenomics (PGx) Product Solution and Service
3.5 Date of Enter into Pharmacogenomics (PGx) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pharmacogenomics (PGx) Historic Market Size by Type (2015-2020)
4.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2021-2026)

5 PHARMACOGENOMICS (PGX) BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pharmacogenomics (PGx) Market Size by Application (2015-2020)
5.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pharmacogenomics (PGx) Market Size (2015-2020)
6.2 Pharmacogenomics (PGx) Key Players in North America (2019-2020)
6.3 North America Pharmacogenomics (PGx) Market Size by Type (2015-2020)
6.4 North America Pharmacogenomics (PGx) Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pharmacogenomics (PGx) Market Size (2015-2020)
7.2 Pharmacogenomics (PGx) Key Players in Europe (2019-2020)
7.3 Europe Pharmacogenomics (PGx) Market Size by Type (2015-2020)
7.4 Europe Pharmacogenomics (PGx) Market Size by Application (2015-2020)

8 CHINA

8.1 China Pharmacogenomics (PGx) Market Size (2015-2020)
8.2 Pharmacogenomics (PGx) Key Players in China (2019-2020)
8.3 China Pharmacogenomics (PGx) Market Size by Type (2015-2020)
8.4 China Pharmacogenomics (PGx) Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pharmacogenomics (PGx) Market Size (2015-2020)
9.2 Pharmacogenomics (PGx) Key Players in Japan (2019-2020)
9.3 Japan Pharmacogenomics (PGx) Market Size by Type (2015-2020)
9.4 Japan Pharmacogenomics (PGx) Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pharmacogenomics (PGx) Market Size (2015-2020)
10.2 Pharmacogenomics (PGx) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmacogenomics (PGx) Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmacogenomics (PGx) Market Size by Application (2015-2020)

11 INDIA

11.1 India Pharmacogenomics (PGx) Market Size (2015-2020)
11.2 Pharmacogenomics (PGx) Key Players in India (2019-2020)
11.3 India Pharmacogenomics (PGx) Market Size by Type (2015-2020)
11.4 India Pharmacogenomics (PGx) Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pharmacogenomics (PGx) Market Size (2015-2020)
12.2 Pharmacogenomics (PGx) Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmacogenomics (PGx) Market Size by Type (2015-2020)
12.4 Central & South America Pharmacogenomics (PGx) Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Details
  13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.1.3 Abbott Laboratories Pharmacogenomics (PGx) Introduction
  13.1.4 Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2015-2020))
  13.1.5 Abbott Laboratories Recent Development
13.2 Affymetrix, Inc.
  13.2.1 Affymetrix, Inc. Company Details
  13.2.2 Affymetrix, Inc. Business Overview and Its Total Revenue
  13.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Introduction
  13.2.4 Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  13.2.5 Affymetrix, Inc. Recent Development
13.3 Assurex Health, Inc
  13.3.1 Assurex Health, Inc Company Details
  13.3.2 Assurex Health, Inc Business Overview and Its Total Revenue
  13.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Introduction
  13.3.4 Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  13.3.5 Assurex Health, Inc Recent Development
13.4 Astrazeneca
  13.4.1 Astrazeneca Company Details
  13.4.2 Astrazeneca Business Overview and Its Total Revenue
  13.4.3 Astrazeneca Pharmacogenomics (PGx) Introduction
  13.4.4 Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  13.4.5 Astrazeneca Recent Development
13.5 GeneDX
  13.5.1 GeneDX Company Details
  13.5.2 GeneDX Business Overview and Its Total Revenue
  13.5.3 GeneDX Pharmacogenomics (PGx) Introduction
  13.5.4 GeneDX Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  13.5.5 GeneDX Recent Development
13.6 Illumina, Inc.
  13.6.1 Illumina, Inc. Company Details
  13.6.2 Illumina, Inc. Business Overview and Its Total Revenue
  13.6.3 Illumina, Inc. Pharmacogenomics (PGx) Introduction
  13.6.4 Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  13.6.5 Illumina, Inc. Recent Development
13.7 Laboratory Corporation of America Holdings
  13.7.1 Laboratory Corporation of America Holdings Company Details
  13.7.2 Laboratory Corporation of America Holdings Business Overview and Its Total Revenue
  13.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Introduction
  13.7.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  13.7.5 Laboratory Corporation of America Holdings Recent Development
13.8 Myriad Genetics, Inc.
  13.8.1 Myriad Genetics, Inc. Company Details
  13.8.2 Myriad Genetics, Inc. Business Overview and Its Total Revenue
  13.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Introduction
  13.8.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  13.8.5 Myriad Genetics, Inc. Recent Development
13.9 Pathway Genomics
  13.9.1 Pathway Genomics Company Details
  13.9.2 Pathway Genomics Business Overview and Its Total Revenue
  13.9.3 Pathway Genomics Pharmacogenomics (PGx) Introduction
  13.9.4 Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  13.9.5 Pathway Genomics Recent Development
13.10 Pfizer, Inc
  13.10.1 Pfizer, Inc Company Details
  13.10.2 Pfizer, Inc Business Overview and Its Total Revenue
  13.10.3 Pfizer, Inc Pharmacogenomics (PGx) Introduction
  13.10.4 Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  13.10.5 Pfizer, Inc Recent Development
13.11 Qiagen, Inc.
  10.11.1 Qiagen, Inc. Company Details
  10.11.2 Qiagen, Inc. Business Overview and Its Total Revenue
  10.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Introduction
  10.11.4 Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  10.11.5 Qiagen, Inc. Recent Development
13.12 Rocheg
  10.12.1 Rocheg Company Details
  10.12.2 Rocheg Business Overview and Its Total Revenue
  10.12.3 Rocheg Pharmacogenomics (PGx) Introduction
  10.12.4 Rocheg Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  10.12.5 Rocheg Recent Development
13.13 Teva Pharmaceutical Industries Ltd.
  10.13.1 Teva Pharmaceutical Industries Ltd. Company Details
  10.13.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
  10.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Introduction
  10.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  10.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
13.14 Thermo Fisher Scientific
  10.14.1 Thermo Fisher Scientific Company Details
  10.14.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  10.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Introduction
  10.14.4 Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  10.14.5 Thermo Fisher Scientific Recent Development
13.15 Transgenomic, Inc.
  10.15.1 Transgenomic, Inc. Company Details
  10.15.2 Transgenomic, Inc. Business Overview and Its Total Revenue
  10.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Introduction
  10.15.4 Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  10.15.5 Transgenomic, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pharmacogenomics (PGx) Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmacogenomics (PGx) Revenue
Table 3. Ranking of Global Top Pharmacogenomics (PGx) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmacogenomics (PGx) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Polymerase Chain Reaction (PCR)
Table 6. Key Players of Microarray
Table 7. Key Players of Sequencing
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Pharmacogenomics (PGx) Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Pharmacogenomics (PGx) Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Pharmacogenomics (PGx) Players to Combat Covid-19 Impact
Table 14. Global Pharmacogenomics (PGx) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Pharmacogenomics (PGx) Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Pharmacogenomics (PGx) Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Pharmacogenomics (PGx) Market Share by Regions (2015-2020)
Table 18. Global Pharmacogenomics (PGx) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Pharmacogenomics (PGx) Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Pharmacogenomics (PGx) Market Growth Strategy
Table 24. Main Points Interviewed from Key Pharmacogenomics (PGx) Players
Table 25. Global Pharmacogenomics (PGx) Revenue by Players (2015-2020) (Million US$)
Table 26. Global Pharmacogenomics (PGx) Market Share by Players (2015-2020)
Table 27. Global Top Pharmacogenomics (PGx) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacogenomics (PGx) as of 2019)
Table 28. Global Pharmacogenomics (PGx) by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Pharmacogenomics (PGx) Product Solution and Service
Table 31. Date of Enter into Pharmacogenomics (PGx) Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Pharmacogenomics (PGx) Market Size by Type (2015-2020) (Million US$)
Table 34. Global Pharmacogenomics (PGx) Market Size Share by Type (2015-2020)
Table 35. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2021-2026)
Table 36. Global Pharmacogenomics (PGx) Market Size Share by Application (2015-2020)
Table 37. Global Pharmacogenomics (PGx) Market Size by Application (2015-2020) (Million US$)
Table 38. Global Pharmacogenomics (PGx) Market Size Share by Application (2021-2026)
Table 39. North America Key Players Pharmacogenomics (PGx) Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Pharmacogenomics (PGx) Market Share (2019-2020)
Table 41. North America Pharmacogenomics (PGx) Market Size by Type (2015-2020) (Million US$)
Table 42. North America Pharmacogenomics (PGx) Market Share by Type (2015-2020)
Table 43. North America Pharmacogenomics (PGx) Market Size by Application (2015-2020) (Million US$)
Table 44. North America Pharmacogenomics (PGx) Market Share by Application (2015-2020)
Table 45. Europe Key Players Pharmacogenomics (PGx) Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Pharmacogenomics (PGx) Market Share (2019-2020)
Table 47. Europe Pharmacogenomics (PGx) Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Pharmacogenomics (PGx) Market Share by Type (2015-2020)
Table 49. Europe Pharmacogenomics (PGx) Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Pharmacogenomics (PGx) Market Share by Application (2015-2020)
Table 51. China Key Players Pharmacogenomics (PGx) Revenue (2019-2020) (Million US$)
Table 52. China Key Players Pharmacogenomics (PGx) Market Share (2019-2020)
Table 53. China Pharmacogenomics (PGx) Market Size by Type (2015-2020) (Million US$)
Table 54. China Pharmacogenomics (PGx) Market Share by Type (2015-2020)
Table 55. China Pharmacogenomics (PGx) Market Size by Application (2015-2020) (Million US$)
Table 56. China Pharmacogenomics (PGx) Market Share by Application (2015-2020)
Table 57. Japan Key Players Pharmacogenomics (PGx) Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Pharmacogenomics (PGx) Market Share (2019-2020)
Table 59. Japan Pharmacogenomics (PGx) Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Pharmacogenomics (PGx) Market Share by Type (2015-2020)
Table 61. Japan Pharmacogenomics (PGx) Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Pharmacogenomics (PGx) Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Pharmacogenomics (PGx) Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Pharmacogenomics (PGx) Market Share (2019-2020)
Table 65. Southeast Asia Pharmacogenomics (PGx) Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Pharmacogenomics (PGx) Market Share by Type (2015-2020)
Table 67. Southeast Asia Pharmacogenomics (PGx) Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Pharmacogenomics (PGx) Market Share by Application (2015-2020)
Table 69. India Key Players Pharmacogenomics (PGx) Revenue (2019-2020) (Million US$)
Table 70. India Key Players Pharmacogenomics (PGx) Market Share (2019-2020)
Table 71. India Pharmacogenomics (PGx) Market Size by Type (2015-2020) (Million US$)
Table 72. India Pharmacogenomics (PGx) Market Share by Type (2015-2020)
Table 73. India Pharmacogenomics (PGx) Market Size by Application (2015-2020) (Million US$)
Table 74. India Pharmacogenomics (PGx) Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Pharmacogenomics (PGx) Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Pharmacogenomics (PGx) Market Share (2019-2020)
Table 77. Central & South America Pharmacogenomics (PGx) Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Pharmacogenomics (PGx) Market Share by Type (2015-2020)
Table 79. Central & South America Pharmacogenomics (PGx) Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Pharmacogenomics (PGx) Market Share by Application (2015-2020)
Table 81. Abbott Laboratories Company Details
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Product
Table 84. Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 85. Abbott Laboratories Recent Development
Table 86. Affymetrix, Inc. Company Details
Table 87. Affymetrix, Inc. Business Overview
Table 88. Affymetrix, Inc. Product
Table 89. Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 90. Affymetrix, Inc. Recent Development
Table 91. Assurex Health, Inc Company Details
Table 92. Assurex Health, Inc Business Overview
Table 93. Assurex Health, Inc Product
Table 94. Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 95. Assurex Health, Inc Recent Development
Table 96. Astrazeneca Company Details
Table 97. Astrazeneca Business Overview
Table 98. Astrazeneca Product
Table 99. Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 100. Astrazeneca Recent Development
Table 101. GeneDX Company Details
Table 102. GeneDX Business Overview
Table 103. GeneDX Product
Table 104. GeneDX Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 105. GeneDX Recent Development
Table 106. Illumina, Inc. Company Details
Table 107. Illumina, Inc. Business Overview
Table 108. Illumina, Inc. Product
Table 109. Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 110. Illumina, Inc. Recent Development
Table 111. Laboratory Corporation of America Holdings Company Details
Table 112. Laboratory Corporation of America Holdings Business Overview
Table 113. Laboratory Corporation of America Holdings Product
Table 114. Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 115. Laboratory Corporation of America Holdings Recent Development
Table 116. Myriad Genetics, Inc. Business Overview
Table 117. Myriad Genetics, Inc. Product
Table 118. Myriad Genetics, Inc. Company Details
Table 119. Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 120. Myriad Genetics, Inc. Recent Development
Table 121. Pathway Genomics Company Details
Table 122. Pathway Genomics Business Overview
Table 123. Pathway Genomics Product
Table 124. Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 125. Pathway Genomics Recent Development
Table 126. Pfizer, Inc Company Details
Table 127. Pfizer, Inc Business Overview
Table 128. Pfizer, Inc Product
Table 129. Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 130. Pfizer, Inc Recent Development
Table 131. Qiagen, Inc. Company Details
Table 132. Qiagen, Inc. Business Overview
Table 133. Qiagen, Inc. Product
Table 134. Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 135. Qiagen, Inc. Recent Development
Table 136. Rocheg Company Details
Table 137. Rocheg Business Overview
Table 138. Rocheg Product
Table 139. Rocheg Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 140. Rocheg Recent Development
Table 141. Teva Pharmaceutical Industries Ltd. Company Details
Table 142. Teva Pharmaceutical Industries Ltd. Business Overview
Table 143. Teva Pharmaceutical Industries Ltd. Product
Table 144. Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 145. Teva Pharmaceutical Industries Ltd. Recent Development
Table 146. Thermo Fisher Scientific Company Details
Table 147. Thermo Fisher Scientific Business Overview
Table 148. Thermo Fisher Scientific Product
Table 149. Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 150. Thermo Fisher Scientific Recent Development
Table 151. Transgenomic, Inc. Company Details
Table 152. Transgenomic, Inc. Business Overview
Table 153. Transgenomic, Inc. Product
Table 154. Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020) (Million US$)
Table 155. Transgenomic, Inc. Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pharmacogenomics (PGx) Market Share by Type: 2020 VS 2026
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Microarray Features
Figure 4. Sequencing Features
Figure 5. Other Features
Figure 6. Global Pharmacogenomics (PGx) Market Share by Application: 2020 VS 2026
Figure 7. Cardiovascular Diseases (CVD) Case Studies
Figure 8. Central Nervous System (CNS) Case Studies
Figure 9. Cancer/Oncology Case Studies
Figure 10. Infectious Diseases Case Studies
Figure 11. Other Case Studies
Figure 12. Pharmacogenomics (PGx) Report Years Considered
Figure 13. Global Pharmacogenomics (PGx) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Pharmacogenomics (PGx) Market Share by Regions: 2020 VS 2026
Figure 15. Global Pharmacogenomics (PGx) Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Pharmacogenomics (PGx) Market Share by Players in 2019
Figure 18. Global Top Pharmacogenomics (PGx) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacogenomics (PGx) as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Pharmacogenomics (PGx) Revenue in 2019
Figure 20. North America Pharmacogenomics (PGx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Pharmacogenomics (PGx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Pharmacogenomics (PGx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Pharmacogenomics (PGx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Pharmacogenomics (PGx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Pharmacogenomics (PGx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Pharmacogenomics (PGx) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Abbott Laboratories Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 29. Affymetrix, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Affymetrix, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 31. Assurex Health, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Assurex Health, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 33. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Astrazeneca Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 35. GeneDX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. GeneDX Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 37. Illumina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Illumina, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 39. Laboratory Corporation of America Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Laboratory Corporation of America Holdings Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 41. Myriad Genetics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Myriad Genetics, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 43. Pathway Genomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Pathway Genomics Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 45. Pfizer, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Pfizer, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 47. Qiagen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Qiagen, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 49. Rocheg Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Rocheg Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 51. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 53. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 55. Transgenomic, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Transgenomic, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed